RGS
Click for more information
0.00% 12.0¢ regeneus ltd

Regeneus joins Austrade’s business mission in Japan Regeneus Ltd...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. xerxer
    739 Posts.
    lightbulb Created with Sketch. 1
    clock Created with Sketch.
    18/04/17
    13:42
    Post #: 24115056
    Regeneus joins Austrade’s business mission in Japan
    Regeneus Ltd (ASX: RGS), a clinical-stage regenerative medicine company, today announced that John Martin, CEO, will be participating in Austrade’s business delegation to Japan on April 18 and 19 being led by the Hon Steven Ciobo MP, Minister for Trade, Tourism and Investments.
    Last edited by xerxer: 18/04/17
    RGS Price at posting: 13.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 
watchlist Created with Sketch. Add RGS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.